G01N 33/5752
Of the lungs
Official title: of the lungs
G01N33/5752 (Of the lungs) appears on 807 US grants and 2,082 published applications in this corpus.
Search patents in G01N- Granted patents
- 807
- Published applications
- 2,082
- Assignees
- 729
- Inventors
- 3,050
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 4 | 0 |
| 1996 | 2 | 0 |
| 1997 | 6 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 13 |
| 2003 | 6 | 507 |
| 2004 | 3 | 27 |
| 2005 | 10 | 35 |
| 2006 | 12 | 63 |
| 2007 | 44 | 58 |
| 2008 | 51 | 33 |
| 2009 | 20 | 57 |
| 2010 | 25 | 75 |
| 2011 | 23 | 73 |
| 2012 | 34 | 85 |
| 2013 | 37 | 76 |
| 2014 | 36 | 87 |
| 2015 | 53 | 103 |
| 2016 | 43 | 111 |
| 2017 | 45 | 85 |
| 2018 | 47 | 79 |
| 2019 | 49 | 63 |
| 2020 | 42 | 83 |
| 2021 | 35 | 70 |
| 2022 | 36 | 66 |
| 2023 | 30 | 57 |
| 2024 | 36 | 69 |
| 2025 | 26 | 59 |
| 2026 | 19 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Molecular profiling of tumors6 Oct 2026US 12,754,193 B2Caris MPI, Inc.
- Method of detecting lung cancer4 Aug 2026US 12,699,096 B2BioMark Cancer Systems Inc.
- Molecular profiling of tumors21 Jul 2026US 12,687,554 B2Caris MPI, Inc.
- Non-invasive gene mutation detection in lung cancer patients23 Jun 2026US 12,662,695 B2The Regents of the University of California
- Method of identifying treatment responsive non-small cell lung cancer using anaplastic lymphoma kinase (ALK) as a marker19 May 2026US 12,631,641 B2Ventana Medical Systems, Inc.
- Anti-human homeobox protein nkx-2.1 antibodies for use in immunohistochemistry (ihc) protocols and for diagnosing cancer24 Sep 2026US 2026/0285955 A1Agilent Technologies, Inc.
- Detection Of Biomarkers For Non-Small Cell Lung Cancer24 Sep 2026US 2026/0287588 A1National University of Singapore
- Biomarkers for lung adenocarcinoma (luad), and method for treating luad10 Sep 2026US 2026/0266822 A1Taipei Veterans General Hospital
- Circulating autoantibody biomarkers to supplement lung cancer screening protocols10 Sep 2026US 2026/0266823 A1
- Biomarkers for predicting cancer treatment efficacy10 Sep 2026US 2026/0266828 A1Arcus Biosciences, Inc.
Most cited
By later US patents
- Balloon dilation catheter256US 5,312,430 A1994
- AIMP2-DX2 gene and SiRNA targeting AIMP2-DX294US 8,003,780 B2Neomics Co., Ltd. · 2011
- Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers93US 10,253,077 B2Immatics Biotechnologies GmbH · 2019
- AIMP2-DX2 and its uses92US 7,459,529 B2Seoul National University Industry Foundation · 2008
- Small cell lung cancer associated antigens and uses therefor85US 7,314,721 B2Ludwig Institute for Cancer Research · 2008